Segui
Ursula Theuretzbacher
Ursula Theuretzbacher
Center for Anti-Infective Agents, Vienna
Email verificata su aon.at - Home page
Titolo
Citata da
Citata da
Anno
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ...
The Lancet infectious diseases 18 (3), 318-327, 2018
48272018
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ...
The Lancet infectious diseases 14 (6), 498-509, 2014
8812014
The global preclinical antibacterial pipeline
U Theuretzbacher, K Outterson, A Engel, A Karlén
Nature Reviews Microbiology 18 (5), 275-285, 2020
5552020
Pharmacokinetic/pharmacodynamic profile of voriconazole
U Theuretzbacher, F Ihle, H Derendorf
Clinical pharmacokinetics 45, 649-663, 2006
5282006
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ...
The lancet Infectious diseases 18 (4), 391-400, 2018
5102018
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
RL Nation, J Li, O Cars, W Couet, MN Dudley, KS Kaye, JW Mouton, ...
The Lancet infectious diseases 15 (2), 225-234, 2015
3772015
Tissue concentrations: do we ever learn?
JW Mouton, U Theuretzbacher, WA Craig, PM Tulkens, H Derendorf, ...
Journal of Antimicrobial Chemotherapy 61 (2), 235-237, 2008
3632008
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
A Huttner, EM Verhaegh, S Harbarth, AE Muller, U Theuretzbacher, ...
Journal of Antimicrobial Chemotherapy 70 (9), 2456-2464, 2015
2992015
Protein binding: do we ever learn?
MA Zeitlinger, H Derendorf, JW Mouton, O Cars, WA Craig, D Andes, ...
Antimicrobial agents and chemotherapy 55 (7), 3067-3074, 2011
2762011
Combination therapy for carbapenem-resistant Gram-negative bacteria
M Paul, Y Carmeli, E Durante-Mangoni, JW Mouton, E Tacconelli, ...
Journal of Antimicrobial Chemotherapy 69 (9), 2305-2309, 2014
2572014
Critical analysis of antibacterial agents in clinical development
U Theuretzbacher, K Bush, S Harbarth, M Paul, JH Rex, E Tacconelli, ...
Nature Reviews Microbiology 18 (5), 286-298, 2020
2512020
Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
JW Mouton, PG Ambrose, R Canton, GL Drusano, S Harbarth, ...
Drug Resistance Updates 14 (2), 107-117, 2011
2492011
Analysis of the clinical antibacterial and antituberculosis pipeline
U Theuretzbacher, S Gottwalt, P Beyer, M Butler, L Czaplewski, ...
The Lancet Infectious Diseases 19 (2), e40-e50, 2019
2272019
Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial
A Huttner, A Kowalczyk, A Turjeman, T Babich, C Brossier, N Eliakim-Raz, ...
Jama 319 (17), 1781-1789, 2018
2142018
Accelerating resistance, inadequate antibacterial drug pipelines and international responses
U Theuretzbacher
International journal of antimicrobial agents 39 (4), 295-299, 2012
2012012
Global antibacterial resistance: The never-ending story
U Theuretzbacher
Journal of global antimicrobial resistance 1 (2), 63-69, 2013
1932013
Non-traditional antibacterial therapeutic options and challenges
U Theuretzbacher, LJV Piddock
Cell host & microbe 26 (1), 61-72, 2019
1722019
Global antimicrobial resistance in Gram-negative pathogens and clinical need
U Theuretzbacher
Current opinion in microbiology 39, 106-112, 2017
1712017
WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ...
Lancet Infect Dis 18 (3), 318-327, 2018
1692018
International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious …
JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ...
Lancet Infect Dis 14 (6), 498-509, 2014
1662014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20